Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24, 2009
27 Août 2009 - 1:30PM
PR Newswire (US)
SEATTLE, Aug. 27 /PRNewswire-FirstCall/ -- Dendreon Corporation
(NASDAQ: DNDN) today announced that the Company will hold an
Analyst Day on Thursday, September 24, 2009 beginning at 8:45 a.m.
ET. A live audio webcast of the presentation will be accessible
through the Investor Relations section of the Dendreon website,
http://www.dendreon.com/. If you are unable to listen to the live
webcast, it will be archived on the site following the
presentation. To access the replay, go to the Investor Relations
section of the website. Dendreon Corporation is a biotechnology
company whose mission is to target cancer and transform lives
through the discovery, development and commercialization of novel
therapeutics. The Company applies its expertise in antigen
identification, engineering and cell processing to produce active
cellular immunotherapy product candidates designed to stimulate an
immune response. Dendreon is also developing an orally-available
small molecule that targets TRPM8 that could be applicable to
multiple types of cancer as well as benign prostatic hyperplasia.
The Company has its headquarters in Seattle, Washington and is
traded on the Nasdaq Global Market under the symbol DNDN. For more
information about the Company and its programs, visit
http://www.dendreon.com/. DATASOURCE: Dendreon Corporation CONTACT:
Jennifer Williams, Investor Relations of Dendreon Corporation ,
+1-206-829-1500 Web Site: http://www.dendreon.com/
Copyright